05/19/2025
3:24 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
9:36 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
10:32 AM | Capital Research Global Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
05/05/2025
3:52 PM | MCKENZIE DIANA (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:55 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:57 PM | Schneider Jennifer (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:14 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:16 PM | CARNEY LLOYD (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:19 PM | Garber Alan M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
8:47 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2025
3:07 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/17/2025
3:08 PM | Upadhyay Suketu (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
10:10 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:11 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
12:58 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
12:02 PM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
11:42 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:08 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:08 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
12:39 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:17 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:43 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:46 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:48 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:31 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:36 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
10:20 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
9:18 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
9:14 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
3:06 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:07 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:09 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:11 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
10:38 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
9:59 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
10:13 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
3:07 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
2:45 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:30 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:31 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:33 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon’s NEXT Big IPO? (Ad) Cancel your internet TODAY!?
Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up.
It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry.
But you may only have this chance if you act before December 31st, 2025. One that experts predict could be worth over $3.2 TRILLION globally by 2030. |
02/19/2025
3:21 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
10:29 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
10:34 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
3:17 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:14 PM | Vertex Pharmaceuticals (Filer)
| Form S-3ASR | |
02/13/2025
3:53 PM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
3:46 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:48 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:50 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:52 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:26 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:21 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:24 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
10:57 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025
10:05 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025
8:49 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
3:43 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:45 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:37 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:38 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:32 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:35 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:07 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
2:51 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
9:31 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
3:15 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
1:58 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
3:11 PM | Vertex Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024
3:12 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:12 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
9:04 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:47 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:23 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:08 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
10:47 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:52 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:17 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
2:34 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
2:25 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:06 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
11:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
12:16 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
9:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
9:23 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:09 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:11 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
8:54 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
8:56 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
Buy VRTX Stock Free VRTX Stock Alerts